The mission of the Aquila Rapid Detection Sensor Platform (RDSP) is to simplify the detection of infectious diseases and bioterrorism threats by putting the power of a diagnostic laboratory into the palm of your hand. Our patented flagship product, the Bacillus anthracis Diagnostics (BaDx) cartridge, provides portable diagnosis of anthrax in a design that is faster, safer, and easier than conventional methods. Future models will be able to detect E.coli, salmonella, valley fever and group A Strep. The Bacillus anthracis Diagnostic (BaDx) cartridge can be used by first responders to quickly screen suspicious powders for anthrax and is also ideal for use in agricultural settings. The patented technology of the BaDx has been licensed by Aquila from Sandia National Laboratories (SNL).

The BaDx is simple, safe, and easy to use. It is a self-contained laboratory, with a sensitivity and accuracy exceeding or rivaling any other detection capability. Its sealed culture chamber amplifies samples prior to introduction to the lateral flow assay (LFA), such that the BaDx is capable of detecting a single spore of Bacillus anthracis.

A Platform for Expansion

The self-contained selective culturing system, magnetic valves, LFA readout, and onboard decontamination agent will all be applied to the detection of other biological agents. SNL and Aquila are currently developing cartridges for other deadly pathogens, such as botulism, salmonella, listeria, and group A strep.

Aquila partnered with Sandia National Laboratories to develop a revolutionary solution for anthrax testing, called BaDx, using ingenious cartridge design and magnetically operated valves so it can be used in a variety of environments, including some very primitive areas of the world. The anthrax cartridge is only the beginning of a new, exciting, and simple-to-use technology for detecting harmful pathogens, such as E.coli, salmonella, valley fever, group A strep, and others.

BaDx Video